Terms: = Uterine cancer AND TP63, EEC3, 8626, ENSG00000073282, p73H, p63, Q9H3D4, TP73L, p51, OFC8, KET, RHS, B p51B , B p51A , SHFM4, LMS, p73L AND Prognosis
104 results:
1. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract] [Full Text] [Related]
2. Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
Li M; Zheng W
Medicine (Baltimore); 2024 Jan; 103(3):e37001. PubMed ID: 38241535
[TBL] [Abstract] [Full Text] [Related]
3. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
[TBL] [Abstract] [Full Text] [Related]
4. POTENTIAL LIFE PROGNOSTIC MARKER FOR MESENCHYMAL TUMOR RESEMBLING uterine LEIOMYOSARCOMA.
Nishikawa S; Hayashi T; Uzaki T; Yaegashi N; Abiko K; Konishi I
Georgian Med News; 2023 Oct; (343):119-126. PubMed ID: 38096528
[TBL] [Abstract] [Full Text] [Related]
5. Ulipristal acetate, a selective progesterone receptor modulator, induces cell death via inhibition of STAT3/CCL2 signaling pathway in uterine sarcoma.
Hwang JR; Cho YJ; Ryu JY; Choi JY; Choi JJ; Sa JK; Kim HS; Lee JW
Biomed Pharmacother; 2023 Dec; 168():115792. PubMed ID: 37924789
[TBL] [Abstract] [Full Text] [Related]
6. Invasive stratified mucin-producing carcinoma (ISMC) of the cervix: a clinicopathological and molecular analysis of 59 cases with special emphasis on histogenesis and potential therapeutic targets.
Yao Y; Wang Y; Ye L; Lu B; Lu W
Histopathology; 2024 Jan; 84(2):315-324. PubMed ID: 37735961
[TBL] [Abstract] [Full Text] [Related]
7. Epithelioid leiomyosarcoma: An unusual presentation.
Kalantri SH; Joseph LD; Priyathersini N; Elangovan B
J Cancer Res Ther; 2023; 19(2):490-492. PubMed ID: 37313923
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic factors, oncological treatment and outcomes of uterine sarcoma: 10 years' clinical experience from a tertiary care center in Pakistan.
Khan SR; Soomar SM; Asghari T; Ahmed A; Moosajee MS
BMC Cancer; 2023 Jun; 23(1):510. PubMed ID: 37277708
[TBL] [Abstract] [Full Text] [Related]
9. Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols.
Yang Z; Yang X; Liu X; Ma K; Meng YT; Yin HF; Wen J; Yang JH; Zhen Z; Feng ZH; Liao QP
BMC Cancer; 2023 Mar; 23(1):243. PubMed ID: 36918828
[TBL] [Abstract] [Full Text] [Related]
10. The biology and treatment of leiomyosarcomas.
Kerrison WGJ; Thway K; Jones RL; Huang PH
Crit Rev Oncol Hematol; 2023 Apr; 184():103955. PubMed ID: 36893945
[TBL] [Abstract] [Full Text] [Related]
11. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
[TBL] [Abstract] [Full Text] [Related]
12. Clinical characteristics and prognosis analysis of uterine sarcoma: a single-institution retrospective study.
Wang F; Dai X; Chen H; Hu X; Wang Y
BMC Cancer; 2022 Oct; 22(1):1050. PubMed ID: 36207687
[TBL] [Abstract] [Full Text] [Related]
13. Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (lms-04): a randomised, multicentre, open-label phase 3 trial.
Pautier P; Italiano A; Piperno-Neumann S; Chevreau C; Penel N; Firmin N; Boudou-Rouquette P; Bertucci F; Balleyguier C; Lebrun-Ly V; Ray-Coquard I; Kalbacher E; Bardet A; Bompas E; Collard O; Isambert N; Guillemet C; Rios M; Archambaud B; Duffaud F;
Lancet Oncol; 2022 Aug; 23(8):1044-1054. PubMed ID: 35835135
[TBL] [Abstract] [Full Text] [Related]
14. [Clinicopathological features of mixed cervical carcinoma with adenoid cystic pattern].
Li LL; Cui YY; Gao PY; Xia L; Liu GZ; Liu H
Zhonghua Bing Li Xue Za Zhi; 2022 Jul; 51(7):615-620. PubMed ID: 35785831
[No Abstract] [Full Text] [Related]
15. Prognostic factors and survival of patients with uterine sarcoma: a German unicenter analysis.
Huss A; Klar M; Hasanov MF; Juhasz-Böss I; Bossart M
Arch Gynecol Obstet; 2023 Mar; 307(3):927-935. PubMed ID: 35780401
[TBL] [Abstract] [Full Text] [Related]
16. Invasive stratified mucin-producing carcinoma (ISMC) of uterine cervix: description of pathological findings and prognosis factors in a series of 15 Chinese patients.
Lin T; Wang W; Xu L; He Y
Arch Gynecol Obstet; 2022 Nov; 306(5):1703-1709. PubMed ID: 35394200
[TBL] [Abstract] [Full Text] [Related]
17. Development, validation, and visualization of a web-based nomogram for predicting the incidence of leiomyosarcoma patients with distant metastasis.
Li Z; Wei J; Cao H; Song M; Zhang Y; Jin Y
Cancer Rep (Hoboken); 2022 May; 5(5):e1594. PubMed ID: 34859618
[TBL] [Abstract] [Full Text] [Related]
18. Targeting Hedgehog Pathway and DNA Methyltransferases in uterine Leiomyosarcoma Cells.
Garcia N; Al-Hendy A; Baracat EC; Carvalho KC; Yang Q
Cells; 2020 Dec; 10(1):. PubMed ID: 33396427
[TBL] [Abstract] [Full Text] [Related]
19. A combination of cytokeratin 5/6, p63, p40 and MUC5AC are useful for distinguishing squamous cell carcinoma from adenocarcinoma of the cervix.
Li H; Jing X; Yu J; Liu J; Zhang T; Chen S; Zhang X
Diagn Pathol; 2020 Aug; 15(1):104. PubMed ID: 32843061
[TBL] [Abstract] [Full Text] [Related]
20. A Real-World Study on Diagnosis and Treatment of uterine Sarcoma in Western China.
Li D; Yin N; Du G; Wang S; Xiao Z; Chen J; Chen W
Int J Biol Sci; 2020; 16(3):388-395. PubMed ID: 32015676
[TBL] [Abstract] [Full Text] [Related]
[Next]
